Oral beclomethasone dipropionate therapy and prognostic plasma biomarkers for gastrointestinal graft-versus-host disease Yoshihiro InamotoAyumu ItoTakahiro Fukuda Original Article 25 March 2025
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma 4. Mantle cell lymphoma (MCL) Kenichi IshizawaKazuhito Yamamoto Guideline 24 March 2025 Pages: 746 - 755
Early cardiotoxicity in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after HLA-haploidentical hematopoietic stem cell transplantation Toshihiro MatsukawaJunichi SugitaTakanori Teshima Original Article 23 March 2025
DLI-induced remission in recurrent EBV-associated T/NK-cell lymphoproliferative disease following HSCT: a case report Toru NagataHirohito KubotaJunko Takita Case Report 21 March 2025 Pages: 862 - 865
Engraftment outcome of patients with anti-HLA antibodies in HLA-mismatched peripheral blood stem cell transplantation Takeshi HaginoKazuhiro Ikegamethe HLA Working Group of Japanese Society for Transplantation, Cellular Therapy Original Article Open access 20 March 2025 Pages: 848 - 856
Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma Soo Chin NgJoon-Ho MoonSuporn Chuncharunee Original Article Open access 20 March 2025 Pages: 670 - 683
JSH Practical Guidelines for Hematological Malignancies, 2023: II. Lymphoma—2. Marginal zone lymphoma: MZL (extranodal marginal zone lymphoma: EMZL [extranodal marginal zone lymphoma of mucosa associated lymphoid tissue], nodal marginal zone lymphoma: NMZL, splenic marginal zone lymphoma: SMZL) Isao Yoshida Guideline 17 March 2025 Pages: 725 - 739
Late-onset radiation necrosis of the larynx attributed to hydroxyurea taken for essential thrombocythemia Masahiro TokunagaAkiyuki YamatoTetsuo Maeda Images in Hematology 17 March 2025 Pages: 723 - 724
Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era Toshihide YoshikawaHisashi IshidaAkihiko Tanizawa Original Article Open access 15 March 2025
Myelodysplastic syndrome with ring chromosomes in a case of dehydrated hereditary stomatocytosis 1 (DHS1) Shinsaku ImashukuYasuhiro KazumaNaoyuki Anzai Case Report 14 March 2025 Pages: 857 - 861
Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE study Tatsunori GotoHiroshi OkamuraTakanori Teshima Original Article Open access 12 March 2025
Effects of tucidinostat in adult T-cell leukemia/lymphoma in clinical practice Ayako KamiuntenTakuro KamedaKotaro Shide Original Article Open access 11 March 2025
Effect of conditioning intensity on late complications in AYA who underwent allogeneic HCT during childhood Maiko ShimomuraMiho AshiaraiKatsutsugu Umeda Original Article 10 March 2025
Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes Takeshi AsanoAkira MorimotoHistiocytosis Study Group of the Japanese Society of Pediatric Hematology/Oncology Original Article 10 March 2025
Retrospective analysis of treatment discontinuation in minimal residual disease negative multiple myeloma Shuku SatoEmi SawazakiYotaro Tamai Original Article 09 March 2025
Anagrelide in the management of essential thrombocythemia: a systemic review and meta-analysis Barbara Abreu LopezJoanne Arvelaez PascucciErnesto Calderon Martinez Original Article 09 March 2025
Primary pancreatic diffuse large B-cell lymphoma, appearing as an asymptomatic bulky mass with the duct-penetrating sign Naonori Harada Images in Hematology 06 March 2025 Pages: 565 - 566
JSH practical guidelines for hematological malignancies, 2023: II. lymphoma—overview Ken Ohmachi Guideline Open access 04 March 2025 Pages: 567 - 576
Prognostic impact of effusion in multiple body cavities after allogeneic hematopoietic stem cell transplantation Yasutaka MasudaAkira HondaMineo Kurokawa Original Article Open access 03 March 2025 Pages: 833 - 847
Extramedullary disease in multiple myeloma at diagnosis and over the course of the disease Murad GuliyevAli TuncAyse Salihoglu Original Article 03 March 2025
JSH practical guidelines for hematological malignancies, 2023: leukemia-5. Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) Yasushi Takamatsu Guideline 01 March 2025 Pages: 432 - 449
Risk of ankylosing spondylitis in long-term follow-up of hematopoietic stem cell donors: impact of HLA-B27 status and donation type Sung-Chao ChuChia-Jung HsiehTso-Fu Wang Original Article 27 February 2025 Pages: 684 - 693
Association between gene mutations and outcomes in Japanese high-risk AML patients: a phase 1/2 study of NS-87/CPX-351 Hideki MakishimaTaisuke MikasaYasushi Miyazaki Original Article Open access 27 February 2025
Simple and early prediction of severe CAR-T-related adverse events after Axi-cel infusion by initial high fever Hiroya WakabayashiSeitaro TerakuraHitoshi Kiyoi Original Article 27 February 2025
Correction: Real‑world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post‑marketing surveillance in Japan Jun-ichi NishimuraTatsuya KawaguchiShoichi Maruyama Correction 26 February 2025 Pages: 560 - 562
Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients Yasutaka MasudaDaichi SadatoNoriko Doki Original Article 26 February 2025 Pages: 820 - 832
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma3. Lymphoplasmacytic lymphoma/Waldenström’s macroglobulinemia (LPL/WM) Isao Yoshida Guideline 25 February 2025 Pages: 740 - 745
Stopping bosutinib reverses bosutinib-induced elevation of serum creatinine in patients with chronic myeloid leukemia Maiko AbumiyaAyano SaitoNaoto Takahashi Original Article Open access 25 February 2025
A novel stroma-dependent leukemia cell line from a patient with mixed-phenotype acute leukemia with Ph chromosome and PAX5 mutation Shoko IshiiYasuhiro ArakawaShingo Yano Original Article 20 February 2025 Pages: 782 - 791
Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations Yosuke MatsumotoDaishi KatoHitoji Uchiyama Original Article 19 February 2025 Pages: 792 - 800
Peritoneal lymphomatosis with CD5-positive diffuse large B-cell lymphoma Satoshi IchikawaShunsuke HattaHideo Harigae Images in Hematology 18 February 2025 Pages: 429 - 431
Zanubrutinib in Japanese treatment-naive and relapsed/refractory patients with Waldenström macroglobulinemia and CLL/SLL Koji IzutsuTakayuki IshikawaMasahiro Takeuchi Original Article Open access 17 February 2025 Pages: 483 - 493
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: significance of guidelines developed for each underlying disease Hidesaku Asakura Progress in Hematology 15 February 2025 Pages: 586 - 591
Correction: Raising awareness may increase the likelihood of hematopoietic stem cell donation: a nationwide survey using artificial intelligence Luana ConteGiorgio De NunzioStefano Botti Correction 13 February 2025 Pages: 563 - 563
Efficacy and safety of the thiotepa–busulfan conditioning regimen as for autologous stem cell transplantation in relapsed/refractory systemic diffuse large B cell lymphoma: a single-center retrospective study Katsuhiro IoKenichi NagaiTomoya Kitagawa Original Article Open access 12 February 2025 Pages: 813 - 819
Iron deficiency anemia following long-term eltrombopag treatment for aplastic anemia: a single-institution experience Ryusuke YamamotoNobuhiro HiramotoTadakazu Kondo Original Article 12 February 2025 Pages: 767 - 773
The novel protein C variant p.C101F results in early intracellular degradation that drives type I protein C deficiency Rikuto YuiSatomi NagayaEriko Morishita Original Article 10 February 2025 Pages: 774 - 781
Recent advances in understanding of pathogenesis and treatment development for diffuse large B-cell lymphoma and follicular lymphoma Daisuke Ennishi Progress in Hematology 10 February 2025 Pages: 318 - 320
Concomitant letermovir affects the optimal concentration-to-dose ratio of tacrolimus after switching from intravenous to oral tacrolimus administration in hematopoietic cell transplantation patients receiving fluconazole prophylaxis Toshihisa NakashimaYoshihiro InamotoHironobu Hashimoto Rapid Communication 10 February 2025 Pages: 462 - 466
Mechanism of antithrombin deficiency due to the novel variant C32W in the C-terminus of the signal peptide Yuika KikuchiSatomi NagayaEriko Morishita Original Article 10 February 2025
Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients Kazuhito SuzukiTadahiro GunjiShingo Yano Original Article 09 February 2025 Pages: 801 - 812
Discovery of a second, distinct development pattern of leukemic conversion from paroxysmal nocturnal hemoglobinuria Junji TokushigeKazuki TaokaMineo Kurokawa Case Report Open access 06 February 2025 Pages: 543 - 546
Rapid tapering of cyclosporine after allogeneic transplantation for high-risk hematological malignancies Ayumi GomyoShinichi KakoYoshinobu Kanda Original Article 06 February 2025 Pages: 504 - 510
Screening for sickle cell anemia in two populations of eastern Gabon using alkaline electrophoresis and hemoglobin level combined with leukocyte count Landry Erick MomboBrice d’Aquin MoreauRomuald Iyedi Likouahan Original Article 05 February 2025 Pages: 653 - 657
Successful treatment of type I cryoglobulinemia with a combination of carfilzomib, cyclophosphamide, and dexamethasone: a case report and literature review Yohei YasudaHiroaki MakiMineo Kurokawa Case Report Open access 04 February 2025 Pages: 411 - 415
Myelodysplastic neoplasms with repeating TAFRO syndrome-like symptoms Kenta HayashinoNobuharu FujiiYoshinobu Maeda Case Report 04 February 2025 Pages: 706 - 711
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma-1. Follicular lymphoma (FL) Koji IzutsuNoriko Fukuhara Guideline 04 February 2025 Pages: 577 - 585
Prognostic value of Glasgow prognostic score in hematological malignancies: a systematic review and meta-analysis Lijun JiangWenting Jin Review Article 03 February 2025 Pages: 450 - 461
Establishment of a high-risk pediatric AML-derived cell line YCU-AML2 with genetic and metabolic vulnerabilities Junji IkedaNorio ShibaShin-Ichi Tsujimoto Original Article 01 February 2025 Pages: 694 - 705
Correction: Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan Hirokazu KashiwagiIsao MiuraMakoto Kanenishi Correction Open access 31 January 2025 Pages: 427 - 427
